Adenocarcinoma of the prostate exhibits a marked propensity to metastasize to the skeleton, where it commonly produces osteoblastic rather than osteolytic lesions. Such lesions appear to be due to increased osteoblast numbers and activity. We have identified apparently unique growth factors for cells of the osteoblast phenotype in freshly isolated human prostatic cancer as well as in benign prostatic hyperplasia. Similar activity was present in normal pre-pubertal but not post-pubertal prostate suggesting androgen dependence. Migogenic acivity was demonstrabel in fetal rat calvarial osteoblasts and in osteoblast- derived osteosarcoma cells, but not in fetal rat skin fibroblasta. Mitogens enhanced alkaline phosphatase activity in osteoblast-like cells. The proposed studies are directed at completing the chemical characterization of the peptides by cloning and sequencing cDNAs encoding the prostatic factors. Sites of non- prostatic tissue production will be determined in human and rat tissues by Northern analysis of extracted poly A + mRNA and by in situ hybridization. Regulation of gene expression by gonadal steroids will be examined in cell cultures of normal, hyperplastic and neoplastic human prostatic tissue and, if appropriate, in transplantable rat models of prostatic adenocarcinoma. The specificity of the mitogenic effects for osteoblasts will be explored in detail and the influences of the factors on other parameters of osteoblasts function (synthesis of type I collagen and production of osteocalcin) will be determined. Monoclonal and polyclonal antibodies will be generated for immunoblotting, immunoneutralization and radioimmunassay studies and in vivo receptor binding studies will be performed to localize cellular skeletal and non-skeletal sites of action. The studies therefore seek to examine the mechanisms whereby metastatic prostatic adenocarcinoma alters skeletal function and aim to characterization growth factors derived from gonadal steroid- dependent tissues, which may mediate effects on the skeleton.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA037126-06
Application #
3174821
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Project Start
1984-09-30
Project End
1990-11-30
Budget Start
1989-12-01
Budget End
1990-11-30
Support Year
6
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Mcgill University
Department
Type
DUNS #
City
Montreal
State
PQ
Country
Canada
Zip Code
H3 0-G4
Rabbani, S A; Gladu, J; Mazar, A P et al. (1997) Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase. J Cell Physiol 172:137-45
Goltzman, D (1997) Mechanisms of the development of osteoblastic metastases. Cancer 80:1581-7
Achbarou, A; Kaiser, S; Tremblay, G et al. (1994) Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res 54:2372-7
Haq, M; Goltzman, D; Tremblay, G et al. (1992) Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. Cancer Res 52:4613-9
Goltzman, D; Bolivar, I; Rabbani, S A (1992) Studies on the pathogenesis of osteoblastic metastases by prostate cancer. Adv Exp Med Biol 324:165-71
Rabbani, S A; Mazar, A P; Bernier, S M et al. (1992) Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J Biol Chem 267:14151-6
Rabbani, S A; Desjardins, J; Bell, A W et al. (1990) An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. Biochem Biophys Res Commun 173:1058-64
Bidner, S M; Rubins, I M; Desjardins, J V et al. (1990) Evidence for a humoral mechanism for enhanced osteogenesis after head injury. J Bone Joint Surg Am 72:1144-9
Bernier, S M; Desjardins, J; Sullivan, A K et al. (1990) Establishment of an osseous cell line from fetal rat calvaria using an immunocytolytic method of cell selection: characterization of the cell line and of derived clones. J Cell Physiol 145:274-85
Koutsilieris, M; Rabbani, S A; Goltzman, D (1987) Effects of human prostatic mitogens on rat bone cells and fibroblasts. J Endocrinol 115:447-54

Showing the most recent 10 out of 12 publications